TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Magnitude of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Musculoskeletal pain level and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes from baseline vital signs, physical examination results, and laboratory test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of upper respiratory infections (URI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Respiratory infection related hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Presence of Bifidobacterium bifidum and Lactobacillus spp in Stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSBMs per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HAMA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HAMD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postural Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to First INR Within Therapeutic Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: dyskinesias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Time to reach a smoothed blood glucose of 70 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infection control
Endpoint domain: Adverse events/effects
Primary endpoint: Intubation Difficulty Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Motor Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse to methamphetamine use
Endpoint domain: Adverse events/effects
Primary endpoint: Liver stiffness (kPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet count (/nl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Alanine-aminotransferase (U/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change in number of patients with alcohol-related negative consequences
Endpoint domain: Adverse events/effects
Primary endpoint: Moderate-severe RSV-LRTD
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Response as Assessed Metabolically by Changes in PET Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of Proliferation (Ki67)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Induction of Apoptosis (TUNEL Assay)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Heart rate variability (HRV) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response to cheese or milk ingestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total Number of PRN Bevacizumab Intravitreal Injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: TB disease outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unpleasant stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of samples with DNA in blastocoele Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in corneal / conjunctival staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Munich Knee Questionnaire (MKQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the concentration time curve (AUC0-12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of plasma homocysteine in fasting state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vascular function, measured as flow mediated vasodilation, in fasting state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Numeric Pain Rating Scale (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Barnason Efficacy Expectation Scale (BEES) - Cardiac Surgery Version
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Readiness for Hospital Discharge Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Peak FXIII Concentration at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough FXIII Concentration at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Peak Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in urethral mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario Rotator Cuff Index (WORC)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive and Negative Symptom Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Psychiatric Rating Scale (BPRS) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression (CGI) Severity Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Antibody Titers to RSV preF Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Solicited Local Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Peripheral IV Access Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ST resolution in ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MBG (myocardial blush grade)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trunk Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The severity of ataxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: The quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Functional Independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Clinical Diagnosis and Physician Management Plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisional Surgical Wound Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Complete resolution of major symptoms (heartburn and acid regurgitation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with minimum plasma of Favipiravir trough concentration above the MEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Blood Lactate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Degree of surface IGF-IR expression in RMS tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent of Liver Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical parameters (IL-32, IL-10 and THF-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in cognitive flexibility performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pk parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in histologic features of nonalcoholic steatohepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of short-term complication
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants with pulmonary atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of infective keratitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Antimicrobial susceptibility and resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Patients Without Distant Metastases
Endpoint domain: Mortality/survival
Primary endpoint: Decrease of signs of skin aging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Action Orientation Questionnaire (HAKEMP)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-efficacy: Thought control of action (SWE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Experiencing and Behaviour post-intervention (VEV)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient/informal caregiver satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants with altered Right ventriculo/arterial (R-V/A) coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in serum choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Freedom from Major Adverse Events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from clinically-driven Target Lesion Revascularization (TLR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Anti-PegG-CSF Antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Change in positive target behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in negative behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Safety of computerized continuous mobilization
Endpoint domain: Adverse events/effects
Primary endpoint: Platelet reactivity measured as PRU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average change in orthostatic heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average change in heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of mCRPC patients with high androgen receptor activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Freedom From Right Atrial (RA) Lead-related Complications in the Acute Period
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom From Right Ventricular (RV) Lead-related Complications in the Acute Time Period
Endpoint domain: Adverse events/effects
Primary endpoint: Intention to use condom if new partner
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude to prevention about HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: toxicity profile of palifermin
Endpoint domain: Adverse events/effects
Primary endpoint: Time to disease recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Volumetric changes in the hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in BDNF concentration in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in regional cerebral blood flow (rCBF) in the frontal lobes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Young Adults Who Received Any Dose of the HPV Vaccine During the Study Period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Young Adults Who Completed the HPV Vaccine Series During the Study Period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Adolescents Who Completed the HPV Vaccine Series During the Study Period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in ALSFRS-R Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet aggregometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incident Rate for Communication Events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of total and LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in clinical asthma score (CAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemoglobin adducts from o-toluidine in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Urinary o-toluidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of NTM in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PK measurement to individualize replacement therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK measurement to influence FVIII consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific pharmacokinetic parameters to analyze
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver stiffness values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sites with no signs of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Toronto Western Spasmodic Torticollis Rating Scale Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of GRF6019
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Participants Experiencing Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of successful procedure completions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NGT insertion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of relapse in pediatric patients with very low risk Wilms tumor
Endpoint domain: Mortality/survival
Primary endpoint: Childhood illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Who Had Concordant Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Discordant Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gambling urges
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gambling-related expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Tolerability Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Academic Self-Concept Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PHQ-9 Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GAD-7 Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in White Blood Cell (WBC) and Absolute Neutrophil Counts (ANC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Episodes of Agranulocytosis
Endpoint domain: Adverse events/effects
Primary endpoint: 24 hour urine sodium and water excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Iron bio-availability (%) from oral iron supplementation (3x 120 mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Iron bio-availability (%) from oral iron supplementation (6x 60 mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum hepcidin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Neurobehavioral Symptom Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of days with improved symptom (dysphagia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Motor functional development or status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yearly changes of morbi-mortality-vital events
Endpoint domain: Mortality/survival
Primary endpoint: Clinical performance of composite strip crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Spent in Hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Relationship Instability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Partner Support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall Facial Improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in facial Sebum production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perceived work ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cricothyroid membrane movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate of PAD induction Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days alive and out of hospital within 14 days after recruitment
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of SPN-812
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Solicited Local Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in estrogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: symptomatic hypotension during dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean 24-hr sABP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Frailty Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Cone Beam Computed Tomography (CBCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Fasting Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Fasting Lipid Profile (Total Cholesterol, HDL, Triglycerides, LDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PCEF of the reflex cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of regulatory T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Soluble MER Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Return to work (RTW)/entry into work or studies
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Magnitude of sick leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Length of sick leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in neonatal adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in maternal postprandial lipemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: success/failure rate of common bile duct stones removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of high grade dysplasia of the bronchial epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Local regional control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Taste perversion scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tolerance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score During Ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Weight From Baseline at 12 Months or More
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body Mass Index (BMI) From Baseline at 12 Months or More
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes